March 14, 2022
The U.S. Agency for International Development has funded a $38 million, five-year project led by UC San Diego researchers to better understand and promote health agency for individuals, communities and local organizations in low- and middle-income countries.
June 30, 2014
…of the Center for Discovery and Innovation in Parasitic Diseases.
July 27, 2015
…to deepen existing collaborative relationships, boost basic research of diseases of the immune system and more quickly introduce new clinical treatments and therapies.
April 11, 2024
University of California San Diego solidified its status as a national leader in National Institutes of Health (NIH) funding, as reported by the 2023 Blue Ridge Institute for Medical Research (BRIMR) rankings.
June 6, 2013
Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.
September 17, 2015
Visible Molecular Cell Consortium will build bridges between disciplines and institutions to assemble and simulate a virtual model of a cell, down to an atomic level of detail.
May 21, 2012
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death…
July 1, 2016
The Human Vaccines Project is teaming with the Qualcomm Institute at the University of California San Diego to apply advances in machine learning to solve critical problems impeding the development of vaccines and therapeutics for a wide range of diseases.
September 14, 2020
UC San Diego researchers demonstrate that one dose of their version of CRISR gene editing can chew up toxic RNA and almost completely reverse symptoms in a mouse model of myotonic dystrophy, a type of adult-onset muscular dystrophy.
May 24, 2012
Antimicrobial peptides (AMPs) are molecules produced in the skin to fend off infection-causing microbes. Vitamin D has been credited with a role in their production and in the body’s overall immune response, but scientists at the University of California, San Diego School of Medicine say a hormone previously associated only…
